Penn Medicine Provider
Gastroenterology
Helen Lee, MD
4.7
(99)
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Penn Presbyterian
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Clinical Assistant Professor of Medicine (Gastroenterology)

Education and training

  • Medical School: Tufts University School of Medicine
  • Residency: Boston Medical Center
  • Fellowship: Hospital of the University of Pennsylvania
  • Fellowship: Allegheny General Hospital

What my patients think about me

Average Rating
4.7

99 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
i'm sorry she's leaving soon
April 2025
5.0
5.0
she's great
March 2025
5.0
5.0
easy to talk to
March 2025
4.0
4.0
she's very good!

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Lee is a Penn Medicine physician.

Qualifications and experience

My research

Bhattacharya A, Travis D, Osterman MT, Lewis JD, Bhagya Rao B, Lee H, Lichenstein GR. Supratherapeutic Infliximab Levels Do Not Predict Risk of Short-term Complications in Adults with Crohn's Disease , J Clin Gastroenterol: 2023

Lee H, Khan N Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease - the IG-IBD LIVE study , Alimentary Pharmacology and Therapeutics: 2022

Lee H, Babich M Autoimmune Liver Disease Variants , Practical Gastroenterology: 2021

Lee H, Schneider Y, Lichtenstein GR Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases , Cancer Screening in Inflammatory Bowel Disease A Guide to Risk Management and Techniques: 2019,95-108

Lee H, Schneider Y, Lichtenstein GR Going Third Class: Treatment of Steroid-Dependent Ulcerative Colitis , Digestive Diseases and Sciences, 64: 2019,1138–1141

Khan N, Lee H, Trivedi C, Kavani H, Medvedeva E, Xie D, Lewis JD, Yang YX Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Disease Treated with Thiopurines , Clinical Gastroenterology and Hepatology, 17(11): 2019,2262-2268

Schneider Y, Lee H, Lichtenstein GR Emergency department visits for inflammatory bowel disease patients are increasing at a steady rate , American College of Gastroenterology, Philadelphia, PA, 113: 2018,S714

Schneider Y, Lee H, Lichtenstein GR The influence of inflammatory bowel disease on the outcome of patients with acute stroke: IBD is not associated with worse outcomes after stroke , American College of Gastroenterology Philadelphia, PA, 113: 2018,S741

Lee H, Schneider Y, Lichtenstein GR Infliximab drug trough levels do not correlate with infectious complication risk in patients with Crohn’s disease , American College of Gastroenterology, Philadelphia, PA, 113: 2018,S633

Schneider Y, Lee H, Lichtenstein GR Elderly age is a Risk factor for severe infections in patients with inflammatory bowel disease , Digestive Disease Week, Washington, DC, 154(6): 2018,S364